Tirzepatide in Australia: Availability, Price & How to Get It (2026)

Tirzepatide is the generic (ingredient) name of the most effective weight loss medication currently approved anywhere in the world. In Australia it's sold as Mounjaro; in the United States it's sold as both Mounjaro and Zepbound. This guide covers the ingredient itself — how it works, the evidence, availability and cost in Australia in 2026.

How tirzepatide works: the dual-agonist difference

Every other weight loss injection in Australia targets one hormone receptor — GLP-1. Tirzepatide targets two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The combination amplifies appetite suppression, improves how your body handles glucose and fat, and appears to be why tirzepatide outperforms single-agonist drugs in head-to-head research.

In practical terms: less hunger, earlier fullness, quieter "food noise", and — in the SURMOUNT-1 trial — average weight loss around 20% of body weight at the top dose over 72 weeks. For comparison, semaglutide (Wegovy) averages about 15%.

Is tirzepatide available in Australia?

Yes. Tirzepatide is TGA-registered and stocked by Australian pharmacies as Mounjaro KwikPen, in six weekly dose strengths from 2.5mg to 15mg. It is prescription-only: an Australian-registered doctor must assess you first. That assessment is exactly what our telehealth GPs do, in a consultation that's bulk billed for eligible Medicare card holders.

How much does tirzepatide cost in Australia?

Because it isn't PBS-subsidised for weight management, you pay the private pharmacy price — indicatively $230–$260 a month at the 2.5mg starting dose, rising with dose to $395–$460 at 15mg. Discount chains like Chemist Warehouse consistently price at the lower end; see the full dose-by-dose breakdown in our Mounjaro pharmacy price guide.

Is compounded tirzepatide legal in Australia?

Be very careful here. Following regulatory changes, compounding pharmacies in Australia face strict limits on replicating commercial GLP-1 medications, and the TGA has repeatedly warned about unregulated "tirzepatide" sold online — dosing accuracy, sterility and even the actual contents are unverified. Buying injectable peptides from overseas websites or "research chemical" suppliers is genuinely dangerous. If cost is the barrier, talk to your GP about starting on a lower dose of the registered product or alternative approaches — our guide to weight loss peptides in Australia covers what's legitimate and what isn't.

Who is tirzepatide suitable for?

Australian GPs generally consider tirzepatide where BMI is 30 or above, or 27+ with at least one weight-related condition (type 2 diabetes, hypertension, obstructive sleep apnoea, PCOS and others). It isn't suitable during pregnancy or breastfeeding, with a personal or family history of medullary thyroid cancer, or with certain gastrointestinal conditions — which is precisely why a proper GP assessment matters.

What are the common side effects?

Mostly gastrointestinal and mostly early: nausea, softer stools or constipation, and reduced appetite (which is partly the point). Side effects typically settle as your body adjusts to each dose step. The titration schedule — starting at 2.5mg and increasing gradually — exists specifically to minimise this. Our honest guide to injection side effects goes deeper, and questions like tiredness on Mounjaro and alcohol interactions have their own guides.

How do I get tirzepatide prescribed?

Request a telehealth appointment — two minutes to book, no referral required. You'll complete a health questionnaire, consult an AHPRA-registered GP by phone or video, and if tirzepatide is clinically appropriate your Mounjaro eScript is sent to your chosen pharmacy the same day.

Clinical information is general in nature — individual suitability requires GP assessment. Prices indicative as at mid-2026.